MaxCyte, Inc. (MXCT)
USD 2.47
(-5.19%)
USD 2.47
(-5.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 36.54 Million USD | -16.86% |
| 2022 | 39.16 Million USD | 29.48% |
| 2021 | 30.24 Million USD | 29.25% |
| 2020 | 23.4 Million USD | 22.39% |
| 2019 | 19.12 Million USD | 28.96% |
| 2018 | 14.82 Million USD | 18.31% |
| 2017 | 12.53 Million USD | 14.32% |
| 2016 | 10.96 Million USD | 32.73% |
| 2015 | 8.25 Million USD | 33.05% |
| 2014 | 6.2 Million USD | 3.51% |
| 2013 | 5.99 Million USD | 41.79% |
| 2012 | 4.22 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.9 Million USD | -10.87% |
| 2024 Q1 | 8.87 Million USD | -31.92% |
| 2023 Q2 | 7.66 Million USD | 1.19% |
| 2023 Q3 | 7.21 Million USD | -5.95% |
| 2023 Q1 | 7.57 Million USD | -30.34% |
| 2023 Q4 | 13.03 Million USD | 80.69% |
| 2023 FY | 32.56 Million USD | -16.86% |
| 2022 Q4 | 10.87 Million USD | 17.29% |
| 2022 Q3 | 9.27 Million USD | 9.27% |
| 2022 Q2 | 8.48 Million USD | -19.36% |
| 2022 FY | 39.16 Million USD | 29.48% |
| 2022 Q1 | 10.52 Million USD | 17.91% |
| 2021 Q4 | 8.92 Million USD | -2.93% |
| 2021 FY | 30.24 Million USD | 29.25% |
| 2021 Q2 | 6.32 Million USD | 8.99% |
| 2021 Q3 | 9.19 Million USD | 45.41% |
| 2021 Q1 | 5.8 Million USD | -23.73% |
| 2020 FY | 23.4 Million USD | 22.39% |
| 2020 Q3 | 6.02 Million USD | 28.69% |
| 2020 Q4 | 7.6 Million USD | 26.2% |
| 2020 Q2 | 4.68 Million USD | -7.85% |
| 2020 Q1 | 5.08 Million USD | -13.78% |
| 2019 Q4 | 5.89 Million USD | 0.0% |
| 2019 FY | 19.12 Million USD | 28.96% |
| 2019 Q3 | 5.89 Million USD | 60.86% |
| 2019 Q2 | 3.66 Million USD | 0.0% |
| 2019 Q1 | 3.66 Million USD | -15.26% |
| 2018 Q4 | 4.32 Million USD | 0.0% |
| 2018 FY | 14.82 Million USD | 18.31% |
| 2018 Q2 | 3.08 Million USD | 0.0% |
| 2018 Q3 | 4.32 Million USD | 40.06% |
| 2018 Q1 | 3.08 Million USD | -11.39% |
| 2017 Q1 | 2.78 Million USD | -8.33% |
| 2017 Q2 | 2.78 Million USD | 0.0% |
| 2017 Q4 | 3.48 Million USD | 0.0% |
| 2017 Q3 | 3.48 Million USD | 25.35% |
| 2017 FY | 12.53 Million USD | 14.32% |
| 2016 Q1 | 2.44 Million USD | 8.22% |
| 2016 FY | 10.96 Million USD | 32.73% |
| 2016 Q4 | 3.03 Million USD | 0.0% |
| 2016 Q3 | 3.03 Million USD | 23.91% |
| 2016 Q2 | 2.44 Million USD | 0.0% |
| 2015 Q3 | 2.26 Million USD | 21.12% |
| 2015 Q2 | 1.86 Million USD | 0.0% |
| 2015 Q1 | 1.86 Million USD | 2.5% |
| 2015 FY | 8.25 Million USD | 33.05% |
| 2015 Q4 | 2.26 Million USD | 0.0% |
| 2014 FY | 6.2 Million USD | 3.51% |
| 2014 Q4 | 1.82 Million USD | 0.0% |
| 2014 Q1 | 1.28 Million USD | 0.0% |
| 2014 Q2 | 1.28 Million USD | 0.0% |
| 2014 Q3 | 1.82 Million USD | 42.16% |
| 2013 FY | 5.99 Million USD | 41.79% |
| 2012 FY | 4.22 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -1333.176% |
| BrainsWay Ltd. | 23.09 Million USD | -58.269% |
| Cerus Corporation | 86.4 Million USD | 57.701% |
| Envoy Medical, Inc. | -473 Thousand USD | 7826.427% |
| electroCore, Inc. | 13.22 Million USD | -176.319% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -59811.475% |
| IceCure Medical Ltd | 1.3 Million USD | -2711.231% |
| Inogen, Inc. | 126.69 Million USD | 71.155% |
| OrthoPediatrics Corp. | 111.25 Million USD | 67.151% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 704.066% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 77305.51% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -7905.397% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -42864.966% |
| Orthofix Medical Inc. | 486.27 Million USD | 92.484% |
| PAVmed Inc | -3.96 Million USD | 1021.018% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 766.29% |
| RxSight, Inc. | 53.76 Million USD | 32.026% |
| Sight Sciences, Inc. | 69.17 Million USD | 47.169% |
| SI-BONE, Inc. | 109.42 Million USD | 66.6% |
| TELA Bio, Inc. | 40.11 Million USD | 8.89% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 75.947% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -341.857% |
| Acutus Medical, Inc. | -3.13 Million USD | 1264.998% |
| Talis Biomedical Corporation | 371 Thousand USD | -9750.674% |
| Spectral AI, Inc. | 7.88 Million USD | -363.782% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 654.399% |
| CVRx, Inc. | 33.03 Million USD | -10.615% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -4841.814% |
| Bioventus Inc. | 328.19 Million USD | 88.864% |
| Venus Concept Inc. | 52.16 Million USD | 29.944% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -129.762% |
| LivaNova PLC | 771.25 Million USD | 95.261% |
| 908 Devices Inc. | 25.32 Million USD | -44.325% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 88.219% |
| Nemaura Medical Inc. | -1.47 Million USD | 2575.359% |
| NeuroPace, Inc. | 48.12 Million USD | 24.056% |
| LENSAR, Inc. | 21.1 Million USD | -73.146% |
| Apyx Medical Corporation | 14.12 Million USD | -158.788% |
| Cutera, Inc. | 41.49 Million USD | 11.925% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -97.963% |
| BioSig Technologies, Inc. | 18 Thousand USD | -202933.333% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 64.549% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -168.444% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 95.886% |
| Axonics, Inc. | 274.55 Million USD | 86.689% |
| Outset Medical, Inc. | 29 Million USD | -26.021% |
| IRIDEX Corporation | 21.8 Million USD | -67.588% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 48.562% |
| IRadimed Corporation | 50.15 Million USD | 27.139% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -12633.798% |
| INVO Bioscience, Inc. | 1.08 Million USD | -3264.766% |
| Telesis Bio, Inc. | 16.95 Million USD | -115.611% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 67.596% |
| Varex Imaging Corporation | 256.9 Million USD | 85.774% |
| Quipt Home Medical Corp. | 163.84 Million USD | 77.695% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 9101.478% |
| Pulmonx Corporation | 50.75 Million USD | 27.991% |
| Dynatronics Corporation | 7.63 Million USD | -378.665% |
| Modular Medical, Inc. | -768 Thousand USD | 4858.594% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -558.724% |
| Semler Scientific, Inc. | 61.2 Million USD | 40.284% |
| InMode Ltd. | 411.34 Million USD | 91.115% |
| Bruker Corporation | 1.51 Billion USD | 97.591% |
| Cytosorbents Corporation | 22.39 Million USD | -63.21% |
| DexCom, Inc. | 2.28 Billion USD | 98.403% |
| Align Technology, Inc. | 2.71 Billion USD | 98.656% |
| Viveve Medical, Inc. | 620 Thousand USD | -5794.516% |
| ZimVie Inc. | 290.38 Million USD | 87.415% |
| Movano Inc. | -158 Thousand USD | 23230.38% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 66.602% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -42864.966% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 90.061% |
| Profound Medical Corp. | 4.51 Million USD | -709.611% |
| Insulet Corporation | 1.15 Billion USD | 96.849% |
| enVVeno Medical Corporation | -546 Thousand USD | 6793.407% |
| Surmodics, Inc. | 93.05 Million USD | 60.725% |
| iCAD, Inc. | 14.53 Million USD | -151.417% |
| Nuwellis, Inc. | 4.98 Million USD | -633.414% |
| Biotricity, Inc. | 8.35 Million USD | -337.348% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 88.986% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 10278.328% |
| InspireMD, Inc. | 1.8 Million USD | -1922.468% |
| PAVmed Inc. | -3.96 Million USD | 1021.018% |
| BIOLASE, Inc. | 16.72 Million USD | -118.524% |
| Beyond Air, Inc. | -1.3 Million USD | 2896.174% |
| FONAR Corporation | 45.14 Million USD | 19.039% |
| AxoGen, Inc. | 127.87 Million USD | 71.42% |
| Vivani Medical, Inc. | -357 Thousand USD | 10336.975% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 81.271% |
| Inari Medical, Inc. | 434.56 Million USD | 91.59% |
| UFP Technologies, Inc. | 112.22 Million USD | 67.435% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -291824.275% |
| Tenon Medical, Inc. | 1.24 Million USD | -2844.883% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 45218.519% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -1291.122% |
| AdaptHealth Corp. | 479.56 Million USD | 92.379% |
| Sintx Technologies, Inc. | 1.84 Million USD | -1882.963% |
| NanoVibronix, Inc. | 1.53 Million USD | -2277.749% |
| Quanterix Corporation | 70.64 Million USD | 48.269% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 9101.478% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -159.929% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 30.758% |
| TransMedics Group, Inc. | 154.09 Million USD | 76.283% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -720.705% |
| NeuroMetrix, Inc. | 3.94 Million USD | -825.822% |
| Hyperfine, Inc. | 4.75 Million USD | -668.257% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 65.838% |
| Biomerica, Inc. | 611 Thousand USD | -5881.342% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 12.333% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 4779.655% |
| Silk Road Medical, Inc | 127.08 Million USD | 71.243% |